Immulite Cea

• • Terminated Z-1678-2018 FDA Class II ·initiated 2 Jan 2018

  Concentrations for the level of biotin that does not interfere is not currently listed in the instruction for use for the Dimension Vista CTNI, Dimension Vista MMB, Dimension Sirolimus, ADVIA Centaur FOL, ADVIA Centaur aHBcM and the following IMMULITE assays, 3gAllergy Specific IgE, anti-HBc, BR-MA (CA15-3), CEA, Folic Acid, Gastrin, OM-MA (CA125), Thyroglobulin, and Vitamin B12, and these assays are susceptible to interference from biotin.

• • Terminated Z-1015-05 FDA Unclassified (pre-2012) ·initiated 26 May 2005

  Adverse trend in stability, controls biased or out of range.

• • Terminated Z-0972-04 FDA Unclassified (pre-2012) ·initiated 3 May 2004

  Instabililty

510(k) Number

K970877 ↗

FDA Product Code

DHX

Device Class

Class II

Regulation

21 CFR Part 866.6010

Advisory Committee

Immunology

FDA Decision

SESE Substantially Equivalent

• Immulite 2000 3RD Generation Psa

  Class II

  FDA 510(k) K974842 Active Cleared 21 Apr 1998

• Immulite Turbo Ck-Mb, Models LSKCP1, LSKCP5

  Class II

  FDA 510(k) K991797 Active Cleared 9 Jun 1999

• Coat-A-Count T4 Ria Kit

  Class II

  FDA 510(k) K811315 Active Cleared 27 May 1981

• Immulite(R) Tbg

  Class I

  FDA 510(k) K950072 Active Cleared 3 Apr 1995

• Immulite 2000 Digoxin, Models L2KDI2 (200 Tests) and L2KDI6 (600 Tests)

  Class II

  FDA 510(k) K012301 Active Cleared 19 Sep 2001

• Coat-A-Count Direct Androstenedione

  Class I

  FDA 510(k) K954755 Active Cleared 29 Nov 1995

See all devices from Diagnostic Products Corp. →